Psychedelic Research Bulletin: January 2022 Post published:February 7, 2022 Post category:Psychedelics Research Review
Psychedelic Bulletin: Patent Granted Covering DMT Vapes; Microdosing Produces “Negligible” Effects Post published:February 6, 2022 Post category:Psychedelic Bulletin
Silo Pharma Extends Exclusive Option Agreement for Homing Peptides Post published:February 3, 2022 Post category:Press Release
Entheon Biomedical Announces the Approval of DMT Clinical Trial Post published:February 3, 2022 Post category:Press Release
MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform Post published:February 3, 2022 Post category:Press Release
Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity Study of AME-1 Post published:February 3, 2022 Post category:Press Release
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its āMicrodosingā Compounds Post published:February 3, 2022 Post category:Press Release
Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member Post published:February 3, 2022 Post category:Press Release
IntelGenx Receives Third Loan Tranche from atai Post published:February 1, 2022 Post category:Press Release